European Journal of Ophthalmology · 2010 · 17 citations · 8 references
MedicineOphthalmologySurgeryOcular DiseaseOphthalmic PathologyOphthalmic SurgeryAge-related Macular DegenerationMacular DegenerationMacular DiseaseRetinal DegenerationRetinal Pigment EpitheliumRetinal Vascular DiseaseAnti-vegf Ocular TherapyDurable Clinical ResponseIntravitreal Anti-vascular Endothelial Growth Factor TherapyRetinal Pigment Epithelium DamageRetinal Pigment Epithelium DegenerationRetrospective Record ReviewVascular Endothelial Growth FactorVascular Endothelial Growth Factor Receptors
PURPOSE: To describe the clinical response following anti-vascular endothelial growth factor (VEGF) therapy in patients with spontaneous retinal pigment epithelium (RPE) tears secondary to age-related macular degeneration (AMD). METHODS: Retrospective chart review of patients with AMD who developed a spontaneous RPE tear and were subsequently treated with anti-VEGF therapy at a single institution. RESULTS: In 5 patients included in the study, the median number (range) of injections received was 14.2 (5-18). The median baseline acuity was 20/200, which remained stable at 12 months and improved to 20/60 at 24 months. These changes were not statistically different. CONCLUSIONS: Anti-VEGF therapy appears safe in eyes with spontaneous RPE tear secondary to AMD and may help to stabilize or even improve acuity in some cases.
8
Tears of detached retinal pigment epithelium.
Annette K. Hoskin, Alan C. Bird, Kulwant Sehmi · British Journal of Ophthalmology · 1981 · 240 citations · Full text
Medicine, Ophthalmology, Surgery +17
RETINAL PIGMENT EPITHELIAL TEARS IN RANIBIZUMAB-TREATED EYES
Bradley T. Smith, Courtney L. Kraus, Rajendra S. Apte · Retina · 2009 · 67 citations
Medicine, Ophthalmology, Surgery +17